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Introduction
T
he World Health Organization (WHO) has 
compared hepatitis C to a “viral time bomb” 
and estimates that about 180 million people (some 
3%  of  the  world’s  population)  are  infected  with 
hepatitis C virus (HCV), 130 million of whom are 
chronic carriers at risk of developing liver cirrhosis 
and/or liver cancer. Three to four million persons are 
newly infected each year, 70% of whom will develop 
chronic hepatitis. HCV is responsible for 50–76% 
of all liver cancer cases, and two thirds of all liver 
transplants in the developed world (1). World Health 
Statistics 2008 lists cirrhosis of the liver as the 18th 
commonest cause of mortality in the world, and it is 
estimated that by 2030, liver cancer will become the 
13th commonest cause (2).
The prevalence of hepatitis varies from country to 
country, and at times it will also vary among different 
regions  of  the  same  country. The  epidemiological 
estimates  by  WHO  show  that  the  prevalence  of 
hepatitis C is low (< 1%) in Australia, Canada and 
northern  Europe,  and  about  1%  in  countries  of 
medium endemicity, such as the USA and most of 
Europe. It is high (>2%) in many countries of Africa, 
Latin America, Central and South-East Asia. In these 
countries, prevalence figures between 5% and 10% 
are frequently reported (1). 
Collecting and comparing health data from across 
a country is a way to describe health problems, identify 
trends and help decision-makers set priorities. The 
global epidemiology of hepatitis C is well established. 
However, its epidemiology in Pakistan is ill-defined. 
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Hepatitis C virus (HCV) infection is increasingly recognized as a major health care problem, and is found frequently 
in Pakistani settings. In this article we reviewed published and unpublished data related to the seroepidemiology of 
HCV infection in Pakistan. For this article, data from 132 published studies and three unpublished data sets published/
presented between the period 1992-2008 were utilized. Data of 1,183,329 individuals were gathered. Blood donors 
(982,481) and the general population (178,322) constituted the majority of these subjects. The frequency of HCV infection 
in blood donors and in the general population was 3.0 % (95% CI: 3.0- 3.1) and 4.7 (95% CI: 4.6 -4.8), respectively. The 
frequency among 6,148 pregnant females was 7.3% (95% CI = 6.7 – 8.0). The frequency in healthy children ranged from 
0.4 to 4.1% (95% CI = 1.4 – 2.3). Pakistani HCV serofrequency figures are significantly higher (P < 0.0001) compared to 
those of the corresponding populations in surrounding countries like India, Nepal, Myanmar, Iran and Afghanistan.
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Most  of  the  data  have  come  from  hospital-based 
studies,  because  there  is  a  dearth  of  community-
based ones  (3-5). Although the National Survey of 
Hepatitis has concluded, its results have not yet been 
officially published, except for a few presentations 
made by researchers at official meetings. This review 
summarizes the available data on the epidemiology 
of hepatitis C since the first report of its recognition 
in 1992.
HCV-Related Pakistani Data
All  available  Pakistani  data  published  or 
unpublished  till  the  writing  of  this  article  were 
collected  by  a  literature  search  through  electronic 
databases  like  Pubmed,  Pakmedinet,  Yahoo  and 
Google  etc.  Unpublished  data  from  any  source, 
if  accessible,  were  also  reviewed.  Data  from  132 
published studies and 3 unpublished data sets were 
gathered and grouped in six categories, based on the 
type of population studied i.e. 1) general population, 
2) blood donors, 3) patients with liver diseases, 4) 
patients with diseases other than hepatic diseases, 5) 
pregnant women and 6) children. Most of the data 
(78.5%) pertained to the years 2001-2008. Year by 
year distribution of this data is given in Table 1.
General Population
Twenty-five  studies  (6-30)  pertained  to  the 
serofrequency  of  hepatitis  C  in  the  general 
population. Details are given in Table 2. The majority 
of these studies (92%) were conducted during the 
period  2000-2008.  Two  studies  were  conducted 
in the nineties (6, 7). The data of 178,322 persons 
were included in this group. Unfortunately, there 
was no study from any major city of Balochistan, or 
from the NWFP provinces. The frequency of HCV 
infection ranged from 0.4% in Karachi (6) to 33.7% 
in Jarwar (Sindh)  (28). The  mean  frequency  was 
4.7% (95% confidence interval [CI]: 4.6 - 4.8).
Blood Donors
Blood donor data constituted the largest data set. 
There were 27 studies and 3 unpublished data sets 
in this group. The total population covered in this 
group was 982,481 over the period 1996-2008 (Table 
3). The studies covered all provinces of Pakistan. The 
serofrequency of HCV ranged from 0.3% in Multan 
(31) to 12.5% in Islamabad (32). The mean frequency 
was 3.0% (95% CI: 3.0- 3.1). Only five studies (29, 
32-35) showed a frequency of > 5%.
Patients with Liver Diseases
Forty-one studies (36-68) dealing with the frequency 
of hepatitis C among patients with liver diseases were 
found, covering 7,765 patients over a period of 27 years 
from 1992 to 2008 (Table 4, and 5). Liver diseases 
included cirrhosis, chronic liver disease, chronic active 
hepatitis and hepatocellular carcinoma.
Fourteen studies  (37-50) pertained  to  cirrhosis 
patients. The number of individuals included in 
these  studies  was  1,902.  HCV  serofrequency  in 
these individuals ranged from 10.5-79.6%, with 
Table 1. Distribution of studies and unpublished data 
sets by year of publication/data gathering/presentation.
        Year  Number Percent
2005 – 2008 47 34.8
2001 – 2004 59 43.7
1996 - 2000  20 14.8
1995 and earlier.  9 6.7
Total  135 100.0
Table 2. Sero-Prevalence of HCV in General Population
Author Year Place Number Anti HCV (%) Reference
Agboatwala et al. 1994 Karachi 258 0.4 (6)
Luby 1997 Hafizabad 313 6.5 (7)
Aslam 2001 Lahore 488 16.0 (8)
Aslam 2001 Gujranwala 1,922 23.8 (8)
Ali et al. 2002 Rawalpindi 5,370 3.3 (9)
Khan 2004 Mardan 700 9.0 (10)
Khokhar 2004 Islamabad 47,538 5.3 (11)
Muhammad 2005 Buner 16,400 4.6 (12)
Farooq et al. 2005 Khuzdar 665 3.3 (13)
Hashim et al.  2005 Attock 4,552 4.0 (14)
Ahmad 2006 Swat 41,613 2.2 (15)
Fayyaz et al. 2006 Bahawalpur 2,086 6.3 (16)
Tariq & Janjua 2006 Rawalpindi 15,550 3.7 (17)
Jafri et al. 2006 Karachi 3,533 1.6 (18)
Sherif & Tariq 2006 Rawalpindi 2,558 2.8 (19)
Zaman  2006 Bahawalpur 6,815 4.4 (30)
Ahmad et al. 2007 Faisalabad 300 16.0 (20)
Altaf et al.  2007 Hyderabad 2,835 5.2 (21)
Mirza et al. 2007 Bahawalpur 1821 2.5 (22)
Malik et al.  2008 Pannu Aqil 5,237 4.8 (23)
Hakim et al.  2007 Karachi 4,000 5.2 (24)
Butt & Amin 2008 DI Khan 5,707 1.7 (25)
Khan et al. 2008 Azad Kashmir 245 3.3 (26)
Idrees et al. 2008 Lahore 6,817 14.6 (27)
Abbas et al.  2008 Jarwar (Sindh) 873 33.7 (28)
Alam et al. 2008 Mianwali 697 1.9 (29)
Total 178,322 4.7 (95% CI: 4.6 -4.8) 6.3)Hepatitis Monthly, Summer 2010; 10(3): 205-214
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an overall prevalence of 44.9% (95% CI = 42.6 – 
47.2). Eleven studies (39, 51-59, 69) covering 3,144 
patients with chronic liver disease showed a range 
of 13.3% to 86.0% HCV serofrequency. The mean 
frequency was 52.9% (95% CI: 51.1-54.7). 
In  10  studies  (36,  39,  40,  42,  60-65)  The  HCV 
serofrequency in 739 cases of hepatocellular carcinoma 
was investigated (Table 5), and it ranged from 24% 
to  67.9%.  The  mean  frequency  in  this  subgroup 
was  50.6%  (95%  CI  :  46.9–54.3).  One  thousand 
nine hundred and eighty patients with acute/chronic 
hepatitis from 6 studies had 58.2% (95% CI : 55.7– 
60.4) HCV serofrequency (46, 51, 57, 66-68).
Patients  with  Diseases  Other  than  Hepatic 
Diseases
Sixteen studies focused on HCV serofrequency in 
patients with various diseases other than liver diseases 
(Table 6) (10, 70-85). These studies spanned a period of 
8 years, from 1999 to 2006, and covered major cities. 
The mean frequency of HCV infection in patients 
with various medical diseases was 20.4% (95% CI : 
18.4-22.5), 38% in haematological diseases (95% CI 
: 33.6-42.5), 7.9% among surgical diseases (95% CI : 
6.9 – 9.0), and 1.3% in dental diseases. 
Pregnant Women
Eleven  studies  (86-96)  dealing  with  the 
serofrequency  of  HCV  among  pregnant  women 
were found (Table 7). These studies spanned a period 
of 13 years from 1996 to 2008 and covered 6,148 
women. The frequency in this group ranged from 
3.3% to 29.1%. Overall serofrequency in this group 
was 7.3% (95% CI = 6.7 – 8.0). 
Children
Data  from  four  studies  (18,  86,  97,  98)  covering 
4,472 healthy children were analyzed (Table 8). HCV 
serofrequency among children ranged from 0.4% to 
Table 3. Sero-prevalence of HCV in Blood Donors.
Author Year Place Number Anti HCV (%) Reference
Kakepoto et al. 1996 Karachi 16,705 1.2 (103)
Bhatti et al.  1996 Rawalpindi 760 4.8 (104)
Lone et al.  1999 Lahore 186 4.3 (105)
Mujeeb  2000 Karachi 612 0.5 (106)
Tanwani & Ahmad 2000 Islamabad 1,345 12.5 (32)
DBTU 2001 UP Rawalpindi 20,500 5.0 (99)
PBTS 2001 UP Lahore 120,000 2.3 (99)
Adridi 2001 UP Peshawar 19,000 4.0 (99)
Ryas et al.  2001 Rawalpindi 1,885 4.7 (107)
Ahmed et al. 2001 Karachi 1,410 4.4 (108)
Ahmad et al. 2002 Lahore 5,789 4.9 (109)
Khattak et al. 2002 Rawalpindi 103,858 4.0 (110)
Fayyaz et al.  2002 Bahawalpur 345 5.6 (33)
Mumtaz et al.  2002 Rawalpindi 553 6.2 (34)
Rahman et al.  2002 Lahore 166,183 4.4 (111)
Ali et al.  2003 Quetta 1635 1.8 (112)
Akhtar et al. 2004 Karachi 351,309 1.8 (113)
Ahmad et al. 2004 Peshawar 4,000 2.2 (114)
Mahmood et al.  2004 Multan 6,000 0.3 (31)
Sirhindi  2006 Lahore 18,216 4.2 (115)
Aziz 2006 Skardu 850 1.1 (116)
Khan  2006 Bahawalpur 27,938 2.5 (117)
Ujjan et al.  2006 Hyderabad 3,677 6.7 (35)
Mujeeb et al.  2006 Karachi 7,325 3.6 (118)
Chaudhary  2007 Rawalpindi 1,428 2.5 (119)
Alam & Naeem 2007 Gilgit 8.949 1.3 (120)
Ishaq et al.  2007 Thatta 310 1.3 (121)
Bhatti et al. 2007 Karachi 94,177 4.2 (122)
Khattak et al.  2008 Peshawar 1,131 4.1 (123)
Mujeeb & Pearce 2008 Karachi 5,345 7.5 (124)
Total     982,481          3.03 (95% CI: 3.0- 3.1)Hepatitis Monthly, Summer 2010; 10(3): 205-214
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Table 4. Sero-Prevalence of HCV in Liver Disease.
Author Year Place Number Anti HCV (%) Reference
Cirrhosis
Malik  1992 Northern Areas 24 13.3 (38)
Malik 1995 Rawalpindi 220 48.0 (39)
Makki 1995 Karachi 67 10.5 (40)
Hussain  1998 Lahore 50 52.0 (14)
Farooqi & Farooqi 1998 Peshawar 410 43.9 (42)
Umar et al. 1999 Rawalpindi 120 58.0 (43)
Mahmood et al.  1999 Karachi 202 37.7 (44)
Liaqat  2000  Karachi 250 43.0 (45)
Shah et al. 2002 Islamabad 108 79.6 (46)
Iqbal 2002 Peshawar 100 41.0 (47)
Khan  2002 Lahore 94 68.0 (56)
Farooqi & Kahan 2002 Swat 55 59.0 (49)
Khurram 2003 Rawalpindi 142 34.1 (50)
Mashud et al. 2004 DI Khan 60 13.3 (125)
Total 1902 44.9 (95% CI = 42.6 – 47.2)
Chronic Liver Disease
Malik 1995 Rawalpindi 45 13.3 (39)
Tong et al.  1996 Rawalpindi 105 22.0 (52)
Sultana et al.  2000 Islamabad 108 29.6 (53)
Younas et al. 2001 Lahore 100 65.0 (94)
Tahir et al.  2001 Lahore 104 43.3 (55)
Khan et al.  2001 Islamabad 323 28.7 (56)
Khokhar  2002 Islamabad  354 86.0 (51)
Khan 2003 Hazara 614 40.8 (57)
Shaikh 2003 Larkana 1,074 51.0 (69)
Bakhtiari et al.  2003 Rawalpindi 97 68.1 (58)
Wazir et al. 2003 Hyderabad  510 59.0 (59)
Total 3144    52.9 ( 95% CI : 51.1 – 54.7)
Table 5. Sero-Prevalence of HCV in Hepato-cellular Carcinoma and Acute/Chronic Hepatitis.
Author Year Place Number Anti HCV (%) Reference
Hepato cellular Carcinoma
Makki 1991 Karachi 25 24.0 (40)
Malik 1995 Rawalpindi 64 25.0 (39)
Mujeeb et al.  1997 Karachi 54 33.0 (60)
Farooqi & Farooqi 2000 Peshawar 56 67.9 (42)
Mumtaz et al.  2001 Rawalpindi 44 54.0 (61)
Khokhar et al.  2003 Islamabad 67 67.0 (72)
Siddiqui 2005 Karachi 100 43.0 (36)
Bilal 2006 Faisalabad 100 66.4 (74)
Almani et al.  2008 Hyderabad 100 52.0 (64)
Abbas et al.  2008 Karachi 129 51.2 (65)
Total 739 50.6 (95% CI =46.9 – 54.3)
Acute /Chronic Hepatitis
Haider et al.  1994 Lahore 94 6.4 (79)
Umer  1999 Rawalpindi 710 70.0 (67)
Almani et al. 2002 Jamshoro 100 9.0 (112)
Khokhar 2002 Islamabad 354 86.0 (51)
Shah et al. 2002 Islamabad 108 79.6 (115)
Khan et al.  2003 Abbotabad 614 40.8 (57)
Total 1980      58.2 (95% CI =55.9 – 60.4) Hepatitis Monthly, Summer 2010; 10(3): 205-214
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36.25%. The mean frequency was 1.8% (95% CI = 
4.6 – 7.5). One study from Lahore in 1996 reported 
a 4.1% perinatal transmission of HCV in children of 
HCV- positive mothers. The serofrequency of HCV 
in thalassemics, and hemophiliacs was 35-42% (75-
78) and 25% (79), respectively.
Discussion
Many researchers have tried to derive a national 
or  regional  figure  for  HCV  serofrequency  based 
on  the  available  data  (99-101).  In  2005,  Umar  M 
and  Khaar  HTB  (99),  from  Rawalpindi,  collected 
data  from  various  studies  and  reported  a  9.8% 
frequency  in  79,192  individuals.  In  2006,  Hafeez 
(99), from Islamabad, collected data from 98 studies 
and produced an estimate of 5.3%. Raja and Janjua 
(101), from Essex (UK), analyzed studies available on 
Medline from 1970 to 2005, and observed that the 
prevalence of HCV infection ranges from 0.4% in 
children, to 1.2% in healthy blood donors. Ali et al. 
Table 6. Seroprevalence among patients of diseases other than Liver Disease.
Author Year Place Disease Number Anti HCV (%) Reference
Medical Diseases
Khan 2004 Mardan General 700 9.0 (10)
Mumtaz & Aftab 2005 Rawalpindi General 264 28.6 (70)
Gul & Iqbal 2003 Lahore Renal Failure 50 68.0 (71)
Khokar et al. 2005 Islamabad Renal Failure 97 23.7 (72)
Qazi et al. 2004 Bahawalpur Diabetes 2 250 27.6 (73)
Bilwani et al.  2004 Karachi Lymphoprolifrative 143 29.2 (89)
Total 1504 20.4 (95% CI = 18.4-22.5) 
Haematological Diseases
Moatter et al.  1999 Karachi β-Thalassemia 100 35.0 (106)
Muhammad J 2003 Peshawar (Thalassemia) β-Thalassemia 80 36.2 (126)
Younus et al. 2004 Islamabad β-Thalassemia 75 42.0 (94)
Burki et al.  2005 Islamabad β-Thalassemia 180 41.7 (74)
Hussain 2001 Peshawar Haemophillia 40 25.0 (14)
Total 475 38 (95% CI = 33.6-42.5)
Psychological Diseases
Shah & Dar  2004 Islamabad Depression 135 22.9 (80)
Surgical Diseases
Hussain & Fatima 2005 Karachi Surgical Diseases 750 16.2 (81)
Talpur et al. 2006 Nawabshah Surgical Diseases 180 11.9 (82)
Khan et al.  2007 Abbottabad Orthopaedic Diseases 1630 3.1 (83)
Daudpota & Soomro 2008 Jacobabad Surgical Diseases 150 14.0 (84)
Total 2710 7.9 (95% CI = 6.9-9.0)
Dental Diseases
Khitab et al. 2005 Peshawar Dental Diseases Diseases 1,498 1.3 (85)
Table 7. Seroprevalence among Pregnant women.
Author Year Place Number Anti HCV (%) Reference
Pregnant Women
Khan  1996 Lahore 417 9.3 (56)
Parker  1999 Lahore 417 4.0 (90)
Zafar et al. 2001 Lahore 300 6.0 (88)
Bilal  2002 Peshawar 352 5.1 (74)
Rizvi  2002 Karachi 120 6.6 (80)
Fayyaz  2004 Lahore 100 7.0 (91)
Khokar et al. 2004 Islamabad 503 4.8 (92)
Jaffery  2005 Islamabad 947 3.3 (93)
Yousafani et al.  2006 Hyderabad 103 29.1 (94)
Hakeem et al. 2006 RY Khan 450 18.2 (41)
Batool et al. 2008 Lahore 2,439 7.3 (99)
Total 6,148            7.3 (95% CI = 6.7 – 8.0) Hepatitis Monthly, Summer 2010; 10(3): 205-214
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According to the “Burden of Disease Study” carried 
out by Hyder and Morrow in 2001, chronic liver 
diseases are the 5th commonest cause of premature 
mortality  in  Pakistan  and  the  11th  commonest 
cause  of  disabilities  (102).  Although  between  75-
85% of infections move on to chronic hepatitis C, 
the progress may be slow. Hence most people who 
are infected do not experience symptoms and are 
unaware of their infection. They are not able to benefit 
from available treatment that may clear them of the 
virus. They may also unknowingly spread the virus 
to others. Currently, there is no vaccine to prevent 
HCV  infection.  Effective  but  costly  treatment  is 
available. The high frequency and its contribution 
to premature mortality and disability call for massive 
awareness campaigns to combat the menace of this 
infectious disease. 
Conclusions
The frequency of hepatitis C infection in Pakistan 
is high (4.7%), varying from 0.4% - 33.7%, indicating 
pockets  of  infections. The  frequency  is  significantly 
higher than in surrounding countries. The contribution 
of  this  high  frequency  to  premature  mortality  and 
disability calls for massive awareness campaigns.
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